Myelomatous pleural effusion in a patient with plasmablastic myeloma: A case report

Diagnostic Cytopathology

Volumn 37, Issue 3, 2009, Pages 205-207

  Chang, Hung ^a   Chou, Wen Chi ^b   Lee, Shen Yang ^a   Huang, Jeng Yi ^a   Hung, Yu Hsin ^a,c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b SAINT PAUL S HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

IgD isotype; Immunophenotypes; Multiple myeloma; Plasmablast; Pleural effusion

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CD19 ANTIGEN; CD38 ANTIGEN; CD79A ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN D LAMBDA; LACTATE DEHYDROGENASE; M PROTEIN; UNCLASSIFIED DRUG; CD79 ANTIGEN;

AGED; ANOREXIA; ARTICLE; BLAST CELL; BLOOD EXAMINATION; BONE MARROW; CASE REPORT; CELL NUCLEUS; CELL SIZE; CYTOLOGY; CYTOPLASM; DIZZINESS; ERYTHROCYTE TRANSFUSION; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; LIGHT CHAIN; MICROSCOPY; MULTIPLE MYELOMA; MYELOMA CELL; NUCLEOLUS; ONSET AGE; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; THORACOCENTESIS; THORAX RADIOGRAPHY; BLOOD; METABOLISM; PATHOLOGY; PLASMA CELL;

AGED, 80 AND OVER; ANTIGENS, CD19; ANTIGENS, CD38; ANTIGENS, CD79; FEMALE; HUMANS; IMMUNOGLOBULIN D; MULTIPLE MYELOMA; PLASMA CELLS; PLEURAL EFFUSION, MALIGNANT;

EID: 64249147899     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21004     Document Type: Article

References (12)

1. Kamble R, Wilson CS, Fassas A, et al. Malignant pleural effusion of multiple myeloma: Prognostic factors and outcome. Leuk Lymphoma 2005;46:1137-1142.
2. Deshpande AH, Munshi MM. Pleural effusion as an initial manifestation of multiple myeloma. Acta Cytol 2000;44:103-104.
3. Inoue Y, Chua K, McClure RF, et al. Multiple myeloma presenting initially as a solitary pleural effusion later complicated by malignant plasmacytic ascites. Leuk Res 2005;29:715-718.
4. Gogia A, Agarwal PK, Jain S, Jain KP. Myelomatous pleural effusion. J Assoc Physicians India 2005;53:734-736.
5. Mason DY, Cordell JL, Brown MH, et al. CD79a: A novel markers for B-cell neoplasms in routinely processed tissue samples. Blood 1995;86:1453-1459.
6. Xu D. Dual surface immunoglobulin light-chain expression in B- cell lymphoproliferative disorders. Arch Pathol Lab Med 2006; 130:853-856.
7. Lin TL, Shih LY, Dunn P, Wang PN, Wu JH, Kao MC. Immunoglobulin D multiple myeloma. Chang Gung Med J 2000;23:451-457.
8. Blade J, Lust JA, Kyle RA. Immunoglobulin D multiple myeloma: Presenting features, response to therapy, and survival in a series of 53 cases. J Chn Oncol 1994; 12:2398-2404.
9. Maeda T, Ashie T, Kikuiri K, et al. A case of IgD multiple myeloma associated with abnormal plasma cells and paraprotein in the pleural fluid. Nippon Naika Gakkai Zasshi 1987;76:1238-1244.
10. Kamal MK, Williams E, Poskitt TR. IgD myeloma with malignant pleural effusion. South Med J 1987;80:657-658.
11. Greipp PR, Raymond NM, Kyle RA, O'Fellon WM. Multiple myeloma: Significance of plasmablastic subtype in morphologic classification. Blood 1985;65:305-310.
12. Lee CK, Ma SK, Shek TWH, et al. Plasmablastic transformation of multiple myeloma. Hum Pathol 2003;34:710-714.